All News

The treatment landscape of triple-negative breast cancer is vastly changing. CURE spoke with Joyce A. O’Shaughnessy, M.D. about what to expect.

A racial disparity exists among patients who die from cervical cancer, according to the results from a recent study.

Perhaps by saying I’ll be fine, you are really saying that you don’t have to think of me in any other way.

Cancer-fighting weapons need to be chosen carefully and deliberately by each individual fighting the battle for their life.

Before passing away from colorectal cancer, Cindy Stowell won over $100,000 in "Jeopardy!" and donated the money toward cancer research.

Car T-Cell therapy is being explored in multiple approaches to treat hematologic malignancies.

A recent study found that having high breast density may actually be a more prevalent risk factor than some of the other common factors.

H. Jack West, M.D., explains how to best optimize the treatment of EGFR-mutated non-small cell lung cancer by using TKIs.

Cancer is really difficult, but if you look hard enough, you might find the perks.

Surviving cancer sometimes means re-imagining the life you dreamed about but never thought you would have.

Patients with certain types of sarcoma may benefit from PD-1 blockades, according to a recent study.

From sweet smoothies and oatmeal to savory soups and stews, Your Cancer Game Plan provides delicious and healthy recipes for patients and survivors in their Let's Get Cooking recipe guide.

There have been exciting developments in the field of HER2-positive breast cancer.

A male breast cancer survivor explains why living with cancer never gets old.

The FDA granted Keytruda a priority review for the treatment of some patients with urothelial carcinoma.

Two-time cancer survivor just doesn't trust the body that betrayed her--twice.

A recent trial showed that ribociclib had the similar benefits for elderly patients with breast cancer as it did for younger patients.

A study being conducted at the MD Anderson Cancer Center is looking at whether certain patients with breast cancer can forgo surgery.

Group exercise programs are beneficial to survivors of cancer, and can offer motivation from peers to continue living a healthy lifestyle.

Oncology stakeholders commented on immigration in general, as well as what President Trump's travel ban may mean for cancer care and research developments.

Researchers found that caregivers have their own concerns and issues when their loved one is transitioning from being a patient in active treatment to a cancer survivor.

Opdivo was granted an accelerated approval for a subset of patients with urothelial carcinoma.

After results from a phase 3 trial showed that Keytruda improved overall survival, it may become the next standard of care for patients with advanced urothelial carcinoma.

John P. Leonard, M.D. spoke with CURE about some upcoming advancements in the treatment of follicular lymphoma.

The American Society of Clinical Oncology named Immunotherapy 2.0 as the Advance of the Year, as it continues to move the cancer field forward.

Feelings of depression can be overwhelming after a diagnosis of breast cancer, and shame is often attached to those feelings.

Three recent trials showed that Keytruda had a durable response for patients with a rare subtype of melanoma.

Jenny C. Chang, M.D., discusses the future of breast cancer care, and what role molecular testing will play.

Diagnostic laparoscopy can play a role in predicting surgery outcomes for patients with ovarian cancer.

20 days without treatment of metastatic cancer is no way to run a nation's health care.